Lamar Smith bought Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)
Lamar Smith (R-TX), a U.S. Representative, has disclosed 1 trade in Ligand Pharmaceuticals Incorporated (LGND) since 2017, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Lamar Smith bought $1,001 - $15,000 of Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) on December 1, 2017. Since that trade, LGND is up +263.75% against the S&P 500 up +220.27%, an outperformance of +43.48%.
Data updated
Lamar Smith's LGND trades vs the price
LGND is up +263.75% since Lamar Smith bought on December 1, 2017, versus +220.27% for the S&P 500.
Performance since this trade
All Lamar Smith LGND trades
Lamar Smith & LGND trading FAQ
Is it legal for Lamar Smith to trade Ligand Pharmaceuticals Incorporated (LGND) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Ligand Pharmaceuticals Incorporated (LGND), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Lamar Smith buy LGND?
Lamar Smith disclosed a purchase of $1,001 - $15,000 of Ligand Pharmaceuticals Incorporated (LGND) on December 1, 2017, according to public STOCK Act filings.
How has LGND performed since Lamar Smith's trade?
Since Lamar Smith bought LGND on December 1, 2017, the stock is up +263.75%, versus +220.27% for the S&P 500 over the same period, an outperformance of +43.48%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional LGND trades?
Quantellect tracks every disclosed congressional trade in Ligand Pharmaceuticals Incorporated (LGND) on the Ligand Pharmaceuticals Incorporated congressional trading page, which aggregates filings across all members of Congress.
Lamar Smith's LGND tradesAll congressional filings for Ligand Pharmaceuticals IncorporatedLamar Smith's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.